| Dr Shravan Kumar Narmala, MD | |
|
2717 Michaelangelo Dr Ste 200, Edinburg, TX 78539-1412 | |
| (956) 362-2250 | |
| (956) 362-2251 |
| Full Name | Dr Shravan Kumar Narmala |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 21 Years |
| Location | 2717 Michaelangelo Dr Ste 200, Edinburg, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700071008 | NPI | - | NPPES |
| 1006394 | Medicaid | LA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Doctors Hospital At Renaissance | Edinburg, TX | Hospital |
| Starr County Memorial Hospital | Rio grande city, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Renaissance Medical Foundation | 1153409867 | 86 |
News Archive
With a $1 million grant from the W. M. Keck Foundation, neuroscience researchers at Washington State University and the University of Massachusetts Amherst will explore whether variations in brain levels of bacterial fragments can account for life's sleep/wake and 24-hour cycles, known as circadian rhythms.
The coronavirus disease 2019 (COVID-19) pandemic has been caused by the rapid outbreak of a novel coronavirus, namely, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). SARS-CoV-2 was first reported in late December 2019 in Wuhan, China. Since then, the virus has already claimed more than 4.3 million lives worldwide.
Epilepsy affects some 50 million people worldwide and pharmaceutical treatment of the disease is a tightrope walk, as the dose must be tailored precisely to the individual patient: "Slightly too little and it isn't effective. Slightly too much and it becomes toxic," explains Professor Pablo Sinues.
Harvard stem cell scientists have discovered that a recently approved medication for epilepsy may possibly be a meaningful treatment for amyotrophic lateral sclerosis (ALS)-Lou Gehrig's disease, a uniformly fatal neurodegenerative disorder. The researchers are now collaborating with Massachusetts General Hospital to design an initial clinical trial testing the safety of the treatment in ALS patients.
› Verified 1 days ago
| Entity Name | Renaissance Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467633867 PECOS PAC ID: 1153409867 Enrollment ID: O20080422000326 |
News Archive
With a $1 million grant from the W. M. Keck Foundation, neuroscience researchers at Washington State University and the University of Massachusetts Amherst will explore whether variations in brain levels of bacterial fragments can account for life's sleep/wake and 24-hour cycles, known as circadian rhythms.
The coronavirus disease 2019 (COVID-19) pandemic has been caused by the rapid outbreak of a novel coronavirus, namely, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). SARS-CoV-2 was first reported in late December 2019 in Wuhan, China. Since then, the virus has already claimed more than 4.3 million lives worldwide.
Epilepsy affects some 50 million people worldwide and pharmaceutical treatment of the disease is a tightrope walk, as the dose must be tailored precisely to the individual patient: "Slightly too little and it isn't effective. Slightly too much and it becomes toxic," explains Professor Pablo Sinues.
Harvard stem cell scientists have discovered that a recently approved medication for epilepsy may possibly be a meaningful treatment for amyotrophic lateral sclerosis (ALS)-Lou Gehrig's disease, a uniformly fatal neurodegenerative disorder. The researchers are now collaborating with Massachusetts General Hospital to design an initial clinical trial testing the safety of the treatment in ALS patients.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shravan Kumar Narmala, MD Po Box 749, Pharr, TX 78577-1614 Ph: (956) 362-2250 | Dr Shravan Kumar Narmala, MD 2717 Michaelangelo Dr Ste 200, Edinburg, TX 78539-1412 Ph: (956) 362-2250 |
News Archive
With a $1 million grant from the W. M. Keck Foundation, neuroscience researchers at Washington State University and the University of Massachusetts Amherst will explore whether variations in brain levels of bacterial fragments can account for life's sleep/wake and 24-hour cycles, known as circadian rhythms.
The coronavirus disease 2019 (COVID-19) pandemic has been caused by the rapid outbreak of a novel coronavirus, namely, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). SARS-CoV-2 was first reported in late December 2019 in Wuhan, China. Since then, the virus has already claimed more than 4.3 million lives worldwide.
Epilepsy affects some 50 million people worldwide and pharmaceutical treatment of the disease is a tightrope walk, as the dose must be tailored precisely to the individual patient: "Slightly too little and it isn't effective. Slightly too much and it becomes toxic," explains Professor Pablo Sinues.
Harvard stem cell scientists have discovered that a recently approved medication for epilepsy may possibly be a meaningful treatment for amyotrophic lateral sclerosis (ALS)-Lou Gehrig's disease, a uniformly fatal neurodegenerative disorder. The researchers are now collaborating with Massachusetts General Hospital to design an initial clinical trial testing the safety of the treatment in ALS patients.
› Verified 1 days ago
Daniela Hernandez, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5423 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-362-3575 Fax: 956-362-3584 | |
Dr. Carlos Javier Cardenas, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5520 Leonardo Da Vinci, Ste 100, Edinburg, TX 78539 Phone: 956-362-3636 Fax: 956-362-2699 | |
Chi Lun Pui, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2821 Michael Angelo, Ste. 400, Edinburg, TX 78539 Phone: 956-362-3553 | |
Dr. Brandon Robert Cantazaro, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5423 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-362-3575 Fax: 956-362-3584 | |
Dr. Roque Masaharu Mifuji Lira, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5501 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-362-3553 Fax: 956-362-3584 | |
Asma Salih Mohammed Tarjmani, Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 5501 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-369-5100 | |
James Walter Castillo Ii, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5501 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-362-8677 Fax: 956-362-7253 |